Akebia Therapeutics (Germany) Today
Akebia Therapeutics is selling for under 0.88 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.88. Equity ratings for Akebia Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Akebia Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akebia Therapeutics stock to make a market-neutral strategy. Peer analysis of Akebia Therapeutics could also be used in its relative valuation, which is a method of valuing Akebia Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Additional Tools for Akebia Stock Analysis
When running Akebia Therapeutics' price analysis, check to measure Akebia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Therapeutics is operating at the current time. Most of Akebia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akebia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Therapeutics' price. Additionally, you may evaluate how the addition of Akebia Therapeutics to your portfolios can decrease your overall portfolio volatility.